Issue 32, 2016

Ultrafast synthesis of stabilized gold nanoparticles using aqueous fruit extract of Limonia acidissima L. and conjugated epirubicin: targeted drug delivery for treatment of breast cancer

Abstract

In this study, a green chemistry approach was used for the quick synthesis (within 30 seconds) of gold nanoparticles (AuNPs) by using the fruit extract of Limonia acidissima L. The study focused on the formation of L. acidissima L. stabilized AuNPs without using any catalytic agent. The synthesis of the AuNPs was confirmed by observation of the surface plasmon resonance (SPR) band at 537 nm. On the surface of these capped AuNPs, epirubicin (EPI) was conjugated along with activated folic acid (FA) for targeted drug delivery. The EPI–FA–AuNPs complex was characterized using FTIR and a UV-visible spectrophotometer and the AuNPs were characterized by HR-TEM, particle size analyzer, and zeta potential measurements. In vitro stability experiments revealed that the AuNPs were stable in physiological conditions. The in vitro cytotoxicity of free EPI and EPI–FA–AuNPs was investigated against MCF-7 cells, and the results showed that 50% of EPI–FA–AuNPs was enough to achieve inhibition of growth (IC50) and that the amount was lower than that of free EPI. Flow cytometry analysis showed significant reduction in G2/M cells after treatment with EPI–FA–AuNPs, and molecular levels of apoptosis were studied using western blotting. Overall, the results revealed that the EPI–FA–AuNPs have better regression activity on tumor cells than free EPI.

Graphical abstract: Ultrafast synthesis of stabilized gold nanoparticles using aqueous fruit extract of Limonia acidissima L. and conjugated epirubicin: targeted drug delivery for treatment of breast cancer

Supplementary files

Article information

Article type
Paper
Submitted
18 Jan 2016
Accepted
06 Mar 2016
First published
08 Mar 2016

RSC Adv., 2016,6, 26874-26882

Ultrafast synthesis of stabilized gold nanoparticles using aqueous fruit extract of Limonia acidissima L. and conjugated epirubicin: targeted drug delivery for treatment of breast cancer

C. S. Kumar, A. Mahesh, M. G. Antoniraj, S. Vaidevi and K. Ruckmani, RSC Adv., 2016, 6, 26874 DOI: 10.1039/C6RA01482H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements